American Conference Institute's 14th National Forum on

Pharmaceutical Compliance and Enforcement

Preventing enforcement actions by mitigating the risk of 'fraud and abuse' and non-compliance activity in the sale, marketing, promotion, research and manufacture of drugs

Wednesday, March 19 to Thursday, March 20, 2014
The Union League of Philadelphia, Philadelphia, PA

American Conference Institute’s 14th National

Pharmaceutical Compliance & Enforcement Forum

Preventing enforcement actions by mitigating the risk of ‘fraud and abuse’ and non-compliant activity in the sale, marketing, promotion, research, and manufacture of drugs

March 19–20, 2014 | The Union League | Philadelphia, PA


In a new era of heightened scrutiny, this is the one place where you can learn how to reduce the risk of massive fines, litigation costs, misconduct charges, guilty pleas, negative publicity and more.  This annual conference will enable you to reshape your compliance programs to reflect recent legislation and changes in enforcement priorities and to develop corporate policies that protect against future fraud claims.ACI is pleased to bring you the next iteration the next iteration of the iconic and industry-leading conference: Fraud and Abuse in the Sale and Marketing of Drugs.  Based on your feedback and the evolution of the industry itself, the program has been expanded to include broader enforcement actions and a more comprehensive focus on building and maintaining a comprehensive and thorough compliance program.

Never before have pharmaceutical companies been so pressured by issues arising simultaneously on the state, national and international level. At this uniquely trying time, day-to-day activities can become the focus of inquiries by members of Congress, investigations by federal and/or state prosecutors, and whistleblower claims.  In addition, increased transparency under the Sunshine Act has both added new compliance challenges and risks associated with intensified public and government scrutiny.

Companies must now focus on revising internal practices to meet the new standards that have been set. They must take extra precaution to ensure that they are minimizing the risk of being accused of engaging in activities that constitute off label promotion or violate the False Claims Act or the FCPA.

This event is supported by the most exciting in-house speakers in the industry who will provide you with a sophisticated and comprehensive understanding of the most difficult and costly issues facing companies today, along with practical strategies for tackling these challenges. 

A recurring highlight of this event is the government enforcement panel where you will hear straight from government enforcers about the most current enforcement priorities, triggers, and targets. 

PLUS two interactive pre- and post-conference workshops:

Workshop A (March 19, 2014) Sunshine Act Compliance Boot Camp— Preparing, Modifying, and Monitoring Data Collection and Reporting Systems: This session will highlight what needs to be reported, discuss gray area issues, and offer practical take-aways for how to avoid becoming a test case.

Workshop B (March 21, 2014) Multi-State Survey—Adjusting Compliance Programs from Standard Models in order to Meet Varied State Guidelines: In the past five years, states have stepped up their enforcement efforts, jointly and individually; and new legislation has either been enacted or looms on the horizon. While some of these provisions parallel federal counterparts, there can be significant differences that have led to state-level enforcement. This interactive session will examine the varying landscape of state laws.

Don’t be the next target of government enforcement – reserve your spot at this event today!  Register by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering online at www.americanconference.com/pharmacompliance.

Full conference details are on the way shortly.  If you are interested in speaking at this event, contact Chris Soverow at c.soverow@americanconference.com.  For information on sponsoring or exhibiting at this event, contact Aaron Goldstein at a.goldstein@americanconference.com.